Optimal Utilization of Thrombolytics
|
|
- Loreen McBride
- 5 years ago
- Views:
Transcription
1 April 8-9, 2011 New York LaGuardia Marriott COMPLETE MANAGEMENT OF VENOUS DISEASE Optimal Utilization of Thrombolytics Anthony J. Comerota, MD, FACS, FACC Director, Jobst Vascular Institute Adjunct Professor of Surgery, University of Michigan
2 Disclosure Anthony Comerota, M.D., FACS, FACC I disclose the following financial relationship(s): Speaker/Honoraria: BMS, Covidien
3 Optimal Utilization of Thrombolytics Issues - Patient Related - 1. Can plasmin be generated within clot? (clot age) 2. Is there underlying venous disease? (correct underlying lesions) 3. Presence of thrombophilia (not an issue!)
4 Optimal Utilization of Thrombolytics Issues - Technical - 1. Can a guideline pass through thrombus? 2. Can intra-thrombus delivery of lytic agent be performed? 3. Bolus delivery vs. continuous infusion 4. Correction of underlying stenosis 5. Adequate inflow to lysed venous segment 6. Addition of IPC 7. Pharmacomechanical techniques
5 Optimal Utilization of Thrombolytics Mechanisms of clot dissolution is activation of fibrin-bound plasminogen (Plasminogen within the clot) Anthony Fletcher Norma Alkjaersig Sol Sherry Diminishes with time!
6 Optimal Utilization of Thrombolytics Intra-Arterial CDT - Randomized Trial - Intra-arterial CDT: More effective than systemic Rx Intra-arterial rt-pa More effective than intra-arterial SK Berridge D et al Br J Surg 1991; 78(8):998
7 Catheter-Directed Thrombolysis Importance of Underlying Lesion Patency at 1 year Intra-Arterial CDT Lesion Corrected McNamara et al, 1986 Yes 80% No 7% Gardiner Same et al, principle 1989 applies to 86% veins (CFV and above) 37%
8 Optimal Utilization of Thrombolytics Presence of Thrombophilia Will not alter management of any patient (for 6-12 months) Might consider evaluation of first degree female relatives of child bearing potential (more during discussion)
9 Catheter-Directed Thrombolysis Determinants of Success Successful Lysis Guidewire Penetration Yes No McNamara et al (N=62) 100% 10% Ouriel et al (N=103) 89% 16% If guidewire passage fails, a chronic venous obstruction exists! McNamara T, et al. AJR 1985;14:764 Ouriel K, et al. Radiol 1994;193:561
10 Catheter-Directed Thrombolysis Intra-Arterial CDT - Bolus vs No Bolus - Infusion time Bolus Yes No 14 hrs. 27 hrs. P = Bolus infusion reduces overall infusion time Ward AS et al JVS 1994; 19:503
11 Catheter-Directed Thrombolysis Intra-Arterial CDT - Bolus vs No Bolus - Successful Lysis at 24 Hours Pulse Spray 78% Slow Infusion <50% Speed of lysis appears related to amount and distribution of plasminogen activator in thrombus Kandarpa K. et al JVIR 1995; 6: 558
12 Optimal Utilization of Thrombolytics Importance of good inflow to lysed proximal veins
13 Phlegmasia Cerulea Dolens 65 yo Caucasian male Chronic low back pain worse x one month Phlegmasia cerulea dolens Venous duplex: Clot post tib Ext. iliac vein
14 Phlegmasia Cerulea Dolens Femoral Popliteal
15 Phlegmasia Cerulea Dolens Posterior Tibial Vein Catheter
16 Phlegmasia Cerulea Dolens US Guided Venous Access Trellis catheter Lysus catheter Isolated segment between balloons Ultrasound transducers
17 Phlegmasia Cerulea Dolens Post Ultrasound Lysis
18 Phlegmasia Cerulea Dolens Post Trellis, LysUS, Angiojet and Stent
19 Phlegmasia Cerulea Dolens 16 Month Follow-up Asymptomatic No PTS symptoms All veins patent Normal deep valve function
20 Catheter-Directed Thrombolysis for IFDVT Is long-term outcome dependent upon lytic success? YES! OK result is NOT good enough!
21 Outcome Measures after IFDVT Lysis Results: Villalta Score vs Percent Lysis Villalte Score Villalta Score Villalta Score Distribution p=0.025 Group <=50% > 50% Group 50% >50% 2 0 Essentially NO PTS with % Percent clot Lysis lysis! Mean Villalta score difference (7.13 versus 2.21) with p-value Grewal P et al Am Ven Forum 2010
22 Optimal Utilization of Thrombolytics Intermittent Pneumatic Compression Prospective, nonrandomized, pilot study Concept: Immobility during CDT IPC increases venous flow 24 patients with CDT for DVT - 10-CDT alone - 14 ODT + IPC (with IVC filter) Low dose urokinase: 240,000 IU X 1hr, 120,000 IU thereafter Pre Rx and post Rx pulmonary angio or CTA chest CDT + IPC post Rx cavagram Post Rx: Venogram Venous disability score Venous duplex Ogawa T et al J Vas Surg 2005
23 Optimal Utilization of Thrombolytics Intermittent Pneumatic Compression Variable - Post Rx Evaluation - CDT Alone (N=6) CDT/IPC (N=14) No Obstruction/Reflux 17% 43% Obstruction 50% 36% Obstruction + reflux 33% 7% Ogawa T et al J Vas Surg 2005
24 Optimal Utilization of Thrombolytics Intermittent Pneumatic Compression Venous Disability Score CDT Alone (N=10) CDT/IPC (N=14) Ogawa T et al J Vas Surg 2005
25 Optimal Utilization of Thrombolytics Pharmacomechanical Techniques Proper use of pharmacomechanical techniques will optimize lytic success
26 Pharmacomechanical Thrombolysis Isolated, Segmental, Pharmacomechanical Thrombolysis rtpa infusion Maceration Trellis Catheter
27 Pharmacomechanical Thrombolysis Ultrasound-Accelerated Thrombolysis EkoSonic Control Unit EkoSonic Mach4 Endovascular Device 5.2 fr Intelligent side-hole drug delivery catheter
28 Pharmacomechanical Thrombolysis Angiojet - Rheolytic Segmental Thrombus
29 CDT Vs PMT Discussion Pharmacomechanical Thrombolysis Martinez J et al JVS 2008; 48:1532 Technique Observations p-value ISPMT Improved lysis Shorter Rx time Reduced tpa dose Lin P H et al Am J Surg 2006; 192:782 Rheolytic Reduced ICU stay Reduced hospital stay Reduced transfusion <.04 <.02 <.05 Parikh S et al JVIR 2008; US Lysis Reduced lytic agent Shorter Rx time <.05 <.05
30 Optimal Utilization of Thrombolytics Summary Guidewire penetration Intrathrombus infusion (saturate thrombus with plasminogen activator) Pulse-spray-bolus dose initially Pharmacomechanical techniques Correct proximal venous lesions (CFV and above) Maximize inflow to lysed proximal veins Persist to remove maximal thrombus Augment lysis with IPC
31
32 Extensive DVT Treated with Once Daily Intra-Clot Injection of rt-pa Study 20 patients: 1 st onset DVT 7 iliofemoral 13 extensive fem-pop Ages years 50mg rt-pa/leg/day maximum mg per cm of thrombus 4 fr catheter left in vein Bedrest X 2hrs then ambulate IPC while in bed IV-UFH to sec Endpoint: antegrade flow Chang R et al Radiology 2008; 246(2):619
33 Extensive DVT Treated with Once Daily Intra-Clot Injection of rt-pa Results 20 patients: 1 st onset DVT 80% antegrade flow (100% in IFDVT) 90% symptom free 40% PE at baseline (asympt) 15% PE during Rx (asympt) No major bleed Follow-up 3.4 years (mean) No PTS No recurrence Chang R et al Radiology 2008; 246(2):619
34 Extensive DVT Treated with Once Daily Intra-Clot Injection of rt-pa Pharmacokinetic Changes Chang R et al Radiology 2008; 246(2):619
Pharmaco-mechanical techniques stand alone procedures? Peter Neglén, MD, PhD SP Vascular Center Limassol Cyprus
Pharmaco-mechanical techniques stand alone procedures? Peter Neglén, MD, PhD SP Vascular Center Limassol Cyprus Faculty Disclosure Peter Neglén, M.D., Ph.D Stockholder/Founder of Veniti, Inc. Member, Medical
More informationSurgical approach for DVT. Division of Vascular Surgery Department of Surgery Seoul National University College of Medicine
Surgical approach for DVT Seung-Kee Min Division of Vascular Surgery Department of Surgery Seoul National University College of Medicine Treatment Options for Venous Thrombosis Unfractionated heparin &
More informationTHERE IS NO ROLE FOR SURGICAL THERAPY FOR DVT
THERE IS NO ROLE FOR SURGICAL THERAPY FOR DVT Tara D. Balint, MD FACS Sentara RMH Thursday, June 14, 2018 1 Objectives of treatment for DVT Prevent death from PE Prevent recurrent VTE Prevent post-thrombotic
More informationVenous interventions in DVT
Venous interventions in DVT Sriram Narayanan Chief of Vascular and Endovascular Surgery, Tan Tock Seng Hospital A/Prof of Surgery, National University of Singapore ANTI-COAGULATION LMWH Warfarin x 6m Acute
More informationShould We Be More Aggressive in the Treatment of Acute DVT?
DISCLOSURES Consultant Penumbra, Inc. UCSF Vascular Surgery Symposium April 6, 2017 K. Pallav Kolli, MD Assistant Professor of Clinical Radiology University of California, San Francisco 17 yo male, DVT
More informationNot all Leg DVT s are the Same: Which Patients Benefit from Interventional Therapy? Case 1:
12/16/2015 Not all Leg DVT s are the Same: Which Patients Benefit from Interventional Therapy? Constantino S.Peña, FSIR, FSCCT, FAHA Interventional Radiologist Medical Director, Vascular Imaging Miami
More informationAggressive endovascular management of ilio-femoral DVT. thrombotic syndrome. is the key in preventing post
CACVS 2017 Aggressive endovascular management of ilio-femoral DVT is the key in preventing post thrombotic syndrome ALI AMIN MD, FACS,FACC, RVT CHIEF OF ENDOVASCULAR INTERVENTIONS READING HEALTH SYSTEM
More informationCopy Here. The Easy One.. What is the Role of Thrombus Removal in Acute Proximal DVT after ATTRACT? Deep Venous Thrombosis Spectrum
What is the Role of Thrombus Removal in Acute Proximal DVT after ATTRACT? Mitchell J. Silver DO FACC FSVM RPVI Director, Center for Critical Limb Care Riverside Methodist Hospital Ohio Health Heart and
More informationVenous Thrombosis. Magnitude of the Problem. DVT 2 Million PE 600,000. Death 60,000. Estimated Cost of VTE Care $1.5 Billion/year.
Venous Thrombosis Magnitude of the Problem DVT 2 Million Postthrombotic Syndrome 800,000 PE 600,000 Death 60,000 Silent PE 1 Million Pulmonary Hypertension 30,000 Estimated Cost of VTE Care $1.5 Billion/year
More informationIliofemoral DVT: Miminizing Post-Thrombotic Syndrome
Iliofemoral DVT: Miminizing Post-Thrombotic Syndrome Catherine K. Chang, MD FACS Vascular Surgery San Diego Southern California Permanente Medical Group Acute Deep Venous Thrombosis Incidence & Outcomes
More informationInterventional Treatment VTE: Radiologic Approach
Interventional Treatment VTE: Radiologic Approach Hae Giu Lee, MD Professor, Dept of Radiology Seoul St. Mary s Hospital The Catholic University of Korea Introduction Incidence High incidence: 250,000-1,000,000/year
More informationIntervention for Deep Venous Thrombosis and Pulmonary Embolus
Intervention for Deep Venous Thrombosis and Pulmonary Embolus Michael R. Jaff, DO Paul and Phyllis Fireman Endowed Chair in Vascular Medicine Massachusetts General Hospital Professor of Medicine Harvard
More information4/23/2009. September 15, 2008
The Current Treatment of Deep Venous Thrombosis: Are We Doing Enough? George H. Meier, MD Professor and Chief Division of Vascular Surgery University of Cincinnati College of Medicine Cincinnati, Ohio
More informationUltrasound-assisted catheter-directed thrombolysis: Does it really work? The BERNUTIFUL trial
Ultrasound-assisted catheter-directed thrombolysis: Does it really work? The BERNUTIFUL trial Rolf P. Engelberger Division of Angiology CHUV, Lausanne & Inselspital, Bern Switzerland Disclosure Speaker
More informationMethods of Thrombus Fragmentation & Extraction. Methods of Thrombus Extraction
Thrombus Fragmentation and Extraction: Clinical Evidence and Practical Application No Relevant Disclosures Venita Chandra, MD Clinical Assistant Professor of Surgery Division of Stanford Medical School,
More informationAcoustic Pulse Thrombolysis Treatment
Acoustic Pulse Thrombolysis Treatment BTGVascular.com SETTING THE STANDARD FOR VASCULAR THERAPIES Quickly & safely dissolve thrombus with the EKOS System. The Acoustic Pulse Difference Acoustic Pulse Thrombolysis
More informationTechniques for thrombus removal in acute DVT Benefits of an Endovascular Approach for Rapid Flow Restoration in DVT
Techniques for thrombus removal in acute DVT Benefits of an Endovascular Approach for Rapid Flow Restoration in DVT Michael K. W. Lichtenberg, MD, FESC Vascular Centre Arnsberg, Germany Disclosure Speaker
More informationPercutaneous Mechanical Thrombectomy for Acute Iliofemoral DVT with the Aspirex Catheter: The Dijon Experience
JFICV 2018, Beaune Percutaneous Mechanical Thrombectomy for Acute Iliofemoral DVT with the Aspirex Catheter: The Dijon Experience Prof. Romaric LOFFROY, MD, PhD, FCIRSE Chief, Department of Vascular and
More informationNATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE INTERVENTIONAL PROCEDURES PROGRAMME Interventional procedure overview of Interventional procedure overview of ultrasound-enhanced, catheterdirected thrombolysis
More informationInnovative Endovascular Approach to Pulmonary Embolism by Ultrasound Enhanced Thrombolysis. Prof. Ralf R.Kolvenbach MD,PhD,FEBVS
Innovative Endovascular Approach to Pulmonary Embolism by Ultrasound Enhanced Thrombolysis Prof. Ralf R.Kolvenbach MD,PhD,FEBVS Catheter-based thrombolysis Local administration of lytic agent Higher local
More informationTechnique de recanalisation: mon expérience avec Aspirex
JFICV 2017, Deauville Thrombose veineuse profonde aiguë en 2017 Technique de recanalisation: mon expérience avec Aspirex Romaric LOFFROY Département de Radiologie Diagnostique et Thérapeutique CHU Hôpital
More informationAcute Venous Thrombosis: Thrombus Removal with Adjunctive Catheter-Directed Thrombolysis (ATTRACT Trial)
Acute Venous Thrombosis: Thrombus Removal with Adjunctive Catheter-Directed Thrombolysis (ATTRACT Trial) N Engl J Med. Volume 377(23):2240-2252. December 7, 2017 Wednesday, July 11, 2018, 1:00pm ET Guest
More informationIleo Femoral DVT Review and Update
Ileo Femoral DVT Review and Update Ammar Safar, MD, FSCAI, FACC, FACP, RPVI Interventional Cardiology & Endovascular Medicine Deep Vein Thrombosis Venous thromboembolism is a major national health problem,
More informationNATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE INTERVENTIONAL PROCEDURES PROGRAMME Interventional procedure overview of Interventional procedure overview of ultrasound-enhanced, catheterdirected thrombolysis
More informationEKOS. Interventional Vascular 3 February, Imagine where we can go.
EKOS Interventional Vascular 3 February, 2015 Imagine where we can go. Forward-looking statement This presentation and information communicated verbally to you may contain certain projections and other
More informationWhat is New in Acute Pulmonary Embolism? Interventional Treatment. Prof. Nils Kucher University Hospital Bern Switzerland
What is New in Acute Pulmonary Embolism? Interventional Treatment Prof. Nils Kucher University Hospital Bern Switzerland nils.kucher@insel.ch Disclosure of Interest Dr. Kucher received research grants
More informationImproved clinical outcomes Evidence on venous thrombectomy followed by stenting
Improved clinical outcomes Evidence on venous thrombectomy followed by stenting Michael K. W. Lichtenberg, MD, FESC Vascular Centre Arnsberg, Germany Venous Centre Arnsberg, Germany Disclosure Speaker
More informationReducing Thrombotic Burden in Arterial Interventions. Mario Galli, MD Cardiovascular Interventional Unit S. Anna Hospital, Como, Italy
Reducing Thrombotic Burden in Arterial Interventions Mario Galli, MD Cardiovascular Interventional Unit S. Anna Hospital, Como, Italy Disclosure Speaker name: Mario Galli... I have the following potential
More informationACUTE LIMB ISCHEMIA Table of Contents
ACUTE LIMB ISCHEMIA Table of Contents PERIPHERAL ARTERIAL DISEASE (PAD)... 1 INTERMITTENT CLAUDICATION (IC)... 1 CRITICAL LIMB ISCHEMIA (CLI)... 1 ACUTE LIMB ISCHEMIA (ALI)... 2 Risk Factors...2 Associated
More informationSuccessful recanalisation of venous thrombotic occlusions with Aspirex mechanical thrombectomy. Michael K. W. Lichtenberg
Successful recanalisation of venous thrombotic occlusions with Aspirex mechanical thrombectomy Michael K. W. Lichtenberg Disclosure Speaker name: Michael Lichtenberg... I have the following potential conflicts
More informationPercutaneously Inserted AngioVac Suction Thrombectomy for the Treatment of Filter-Related. Iliocaval Thrombosis
Percutaneously Inserted AngioVac Suction Thrombectomy for the Treatment of Filter-Related Iliocaval Thrombosis Faiz D. Francis, DO; Gianvito Salerno, MD; Sabbah D. Butty, MD Abstract In the setting of
More informationThrombolysis in Critical Limb Ischemia Frank J. Arena, MD, FACC, FSCAI
Thrombolysis in Critical Limb Ischemia Frank J. Arena, MD, FACC, FSCAI Chairman, Dept. of Cardiology Tulane University-Lakeview Campus Covington, La. Disclosures Sadly-None What are the Goals of Thrombolysis
More informationPEARL Registry Update Overview Venous Arterial AV Access
PEARL Registry Update Overview Venous Arterial AV Access PEARL Registry Overview (as of 10 Sep12*) Overview Venous Arterial AV Access HOME Topic Data Support Comments Study Design Prospective, non-randomized,
More informationMeissner MH, Gloviczki P, Comerota AJ, Dalsing MC, Eklof BG, Gillespie DL, et al. J Vasc Surg. 2012;55:
Early thrombus removal strategies for acute deep venous thrombosis: Clinical Practice Guidelines of the Society for Vascular Surgery and the American Venous Forum Meissner MH, Gloviczki P, Comerota AJ,
More informationVenous stenting in Marseille
Venous stenting in Marseille Olivier HARTUNG, MD, MSc CHU Nord, Marseille, FRANCE Disclosure Speaker name: Olivier HARTUNG I have the following potential conflicts of interest to report: x Consulting :
More information5 year quality of life data after EKOS treatment in acute DVT
5 year quality of life data after EKOS treatment in acute DVT Jochen Grommes MD European Vascular Center Aachen-Maastricht GxUS-EKO-2016-0006 LINC 2016 Disclosure of speaker s interests conflict of interest
More informationImproved clinical outcomes Evidence on venous mechanical thrombectomy followed by stenting
Improved clinical outcomes Evidence on venous mechanical thrombectomy followed by stenting Michael K. W. Lichtenberg, MD, FESC Vascular Centre Arnsberg, Germany German Venous Centre Arnsberg, Germany Disclosure
More informationMark H. Meissner, MD Peter Gloviczki Professor of Venous & Lymphatic Disorders University of Washington School of Medicine
Pulmonary Embolism Response Teams Not So Fast Early Interventions is a House of Cards Mark H. Meissner, MD Peter Gloviczki Professor of Venous & Lymphatic Disorders University of Washington School of Medicine
More informationJ Jpn Coll Angiol, 2009, 49:
Online publication August 27, 2009 1 2 J Jpn Coll Angiol, 2009, 49: 247 254 deep vein thrombosis, thrombolytic therapy, catheter-directed thrombolysis, inferior vena cava filter, pulmonary thromboembolism
More informationManagement of Acute DVT Extending From the Tibial Veins to the Common Iliac Vein Using the AngioJet Thrombectomy System
FEATURED TECHNOLOGY: ANGIOJET THROMBECTOMY SYSTEM Sponsored by Boston Scientific Corporation Management of Acute DVT Extending From the Tibial Veins to the Common Iliac Vein Using the AngioJet Thrombectomy
More informationTreatment of Chronic DVT with EKOS: Reproducing ACCESS PTS Data in Every Day Clinical Practice
Treatment of Chronic DVT with EKOS: Reproducing ACCESS PTS Data in Every Day Clinical Practice Mert Dumantepe, MD Acibadem Altunizade Hospital, Istanbul, Turkey Department of Cardiovascular Surgery Disclosure
More informationThrombolysis versus thrombectomy in acute deep vein thrombosis
review Thrombolysis versus thrombectomy in acute deep vein thrombosis Deep vein thrombosis (DVT) is a significant health problem leading to the admission of over 250,000 Americans each year. Its most serious
More informationDEEP VENOUS THROMBOSIS A PRACTICAL APPROACH TO IMPROVING CLINICAL OUTCOMES
DEEP VENOUS THROMBOSIS A PRACTICAL APPROACH TO IMPROVING CLINICAL OUTCOMES Jose M. Borromeo M.D. Vascular Surgeon Iowa Heart Center Disclosures: AstraZeneca Pharmaceuticals Cook CVRx LeMaitre Vascular,
More informationInterventional Management of Acute Pulmonary Embolism
Interventional Management of Acute Pulmonary Embolism Prof. Nils Kucher Angiology & Cardiology University Hospital Bern Inselspital nils.kucher@insel.ch DECLARATION OF CONFLICT OF INTEREST Consultant to
More informationInnovative Endovascular Approach to Pulmonary Embolism by Ultrasound Enhanced Thrombolysis. Prof. Ralf R.Kolvenbach MD,PhD,FEBVS
Innovative Endovascular Approach to Pulmonary Embolism by Ultrasound Enhanced Thrombolysis Prof. Ralf R.Kolvenbach MD,PhD,FEBVS Conflict of Interest BTG Standard PE therapy ANTICOAGULATION (AC) HEPARIN
More informationENHANCING YOUR OPTIONS
ANGIOJET ULTRA Thrombectomy System ENHANCING YOUR OPTIONS FOR RESTORING FLOW When you need the versatility and power to restore flow Refined from experience in over 700,000 cases worldwide, today s AngioJet
More informationPEARL REGISTRY Post Market Registry
PEARL REGISTRY Post Market Registry Real World Use of the AngioJet Thrombectomy System in the Peripheral Vascular System PI-315422-AA JUN2015 Objectives AngioJet Action Enrollment General Indications &
More informationThe hallmark of percutaneous thrombus management
Treating Venous Thromboembolism Without Lytic Medications What the present and the near future will bring in terms of techniques and devices to remove venous thrombus. BY CONSTANTINO S. PEÑA, MD; RIPAL
More informationComplex Iliocaval Reconstruction PNEC. Seattle WA. Bill Marston MD Professor, Div of Vascular Surgery University of N.
Complex Iliocaval Reconstruction 2017 PNEC. Seattle WA Bill Marston MD Professor, Div of Vascular Surgery University of N. Carolina DISCLOSURES William Marston, MD Consultant/Advisory Board: Veniti, Cardinal
More informationThe hallmark of percutaneous thrombus management
Treating Venous Thromboembolism Without Lytic Medications What the present and the near future will bring in terms of techniques and devices to remove venous thrombus. BY CONSTANTINO S. PEÑA, MD; RIPAL
More informationAspirex for Upper and Lower Extremity DVT
Aspirex for Upper and Lower Extremity DVT Steven Kum MD Vascular & Endovascular Surgeon Director of Vascular Service Changi General Hospital Singapore Disclosure Speaker name:... I have the following potential
More informationManagement of Post-Thrombotic Syndrome
Management of Post-Thrombotic Syndrome Thanainit Chotanaphuti Phramongkutklao College of Medicine Bangkok, Thailand President of CAOS Asia President of Thai Hip & Knee Society President of ASEAN Arthroplasty
More informationNo financial disclosures
7/23/2013 Which patients with acute lower extremity DVT should definitely, probably, and possibly be treated with catheter directed thrombolysis? Akhilesh K. Sista, M.D. Assistant Professor, Division of
More informationCanadian Society of Internal Medicine Annual Meeting 2017 Toronto, ON
Canadian Society of Internal Medicine Annual Meeting 2017 Toronto, ON How to Prevent and Manage the Post-Thrombotic Syndrome? Jean-Philippe Galanaud Clinical Thromboembolism & Division of GIM Sunnybrook,
More informationVERNACULAR Trial & Clinical Experience with the VENOVO Venous Stent
Stephen Black, MD VERNACULAR Trial & Clinical Experience with the VENOVO Venous Stent 1 Speaker Disclaimers The speakers presentation today is on behalf of Bard Peripheral Vascular, Inc. Any discussion
More informationMichael Meuse, M.D. Vascular and Interventional Radiology
Michael Meuse, M.D. Vascular and Interventional Radiology Iliac Vein Compression Syndrome Left CIV compressed by right CIA Virchow 1851: DVT L>R May and Thurner 1954: venous spurs Cockett and Thomas 1965:
More informationDeep Venous Thrombosis: The Opportunity at Hand
Vascular and Interventional Radiology Review Vedantham DVT: The Opportunity at Hand Vascular and Interventional Radiology Review Suresh Vedantham 1 Vedantham S FOCUS ON: Keywords: ATTRACT Trial, deep venous
More informationEmerging Tools for Lytic-Free, Single-Session Treatment of Venous Thromboembolic Disease
FEATURED TECHNOLOGY THE CLOTTRIEVER AND FLOWTRIEVER SYSTEMS Emerging Tools for Lytic-Free, Single-Session Treatment of Venous Thromboembolic Disease The ClotTriever Outcomes (CLOUT) registry principal
More informationIliofemoral venous thrombosis
Iliofemoral venous thrombosis Anthony J. Comerota, MD, and Marilyn H. Gravett, MFA, Toledo, Ohio Iliofemoral deep vein thrombosis (DVT) is associated with serious short- and long-term physical, social,
More informationCatheter-directed thrombolysis of deep vein thrombosis: literature review and practice considerations
Review Article Catheter-directed thrombolysis of deep vein thrombosis: literature review and practice considerations Drew Fleck 1, Hassan Albadawi 1, Fadi Shamoun 2, Grace Knuttinen 1, Sailendra Naidu
More informationImplications from the ACCP 2012 Consensus Guidelines for the Management of Thrombosis: a case based approach
Implications from the ACCP 2012 Consensus Guidelines for the Management of Thrombosis: a case based approach Prof. I. Baumgartner Head Clinical and Interventional Angiology About the ACCP guidelines Widely
More informationNational Institute for Health and Care Excellence
National Institute for Health and Care Excellence IP1219 Ultrasound enhanced catheter-directed thrombolysis for deep vein thrombosis Consultation table IPAC date: Thursday 12 March 2015 Com. 1 3 NHS Professional
More informationThe Evidence Base for Treating Acute DVT
The Evidence Base for Treating Acute DVT Mr Chung Sim Lim Consultant Vascular Surgeon and Honorary Lecturer Royal Free London NHS Foundation Trust and University College London NIHR UCLH Biomedical Research
More informationUse of EKOS Catheter in the management of Venous Mr. Manoj Niverthi, Mr. Sarang Pujari, and Ms. Nupur Dandavate, The GTF Group
Use of EKOS Catheter in the management of Venous Thromboembolism @ Mr. Manoj Niverthi, Mr. Sarang Pujari, and Ms. Nupur Dandavate, The GTF Group Introduction Georgia Thrombosis Forum (GTF, www.gtfonline.net)
More informationAn association between venous thrombosis and
Venous Emergencies in Cancer Patients Endovascular approaches for managing and treating emergent conditions. BY KEVIN SEALS, MD; SCOTT GENSHAFT, MD; RAMSEY AL-HAKIM, MD; BRIAN DUBIN, MD; AND STEPHEN KEE,
More informationSingle Center 4 year series of 114 consecutive patients treated for massive and submassive PE. Mark Goodwin, MD
Single Center 4 year series of 114 consecutive patients treated for massive and submassive PE Mark Goodwin, MD Disclosure Speaker name:... I have the following potential conflicts of interest to report:
More informationUltrasound-enhanced, catheter-directed thrombolysis for pulmonary embolism
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Interventional procedure consultation document Ultrasound-enhanced, catheter-directed thrombolysis for pulmonary embolism A pulmonary embolism (PE) is
More informationWHO YOU GONNA CALL? CLOT-BUSTERS!
WHO YOU GONNA CALL? CLOT-BUSTERS! Jayer Chung MD, MSc Assistant Professor Division of Vascular Surgery and Endovascular Therapy Michael E DeBakey Department of Surgery Baylor College of Medicine Annual
More information- Our patients with iliofemoral DVT - Effective thrombus removal with purely mechanical thrombectomy can lead to better outcomes
- Our patients with iliofemoral DVT - Effective thrombus removal with purely mechanical thrombectomy can lead to better outcomes Michael K. W. Lichtenberg, FESC Conflict of Interest - Disclosure Within
More informationWe are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 3,700 108,500 1.7 M Open access books available International authors and editors Downloads Our
More informationEarly clinical outcomes of a novel rheolytic directional thrombectomy technique for patients with iliofemoral deep vein thrombosis
56 Original communication Early clinical outcomes of a novel rheolytic directional thrombectomy technique for patients with iliofemoral deep vein thrombosis Jörn F. Dopheide 1, Tim Sebastian 1, Rolf P.
More informationWe are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 3,700 108,500 1.7 M Open access books available International authors and editors Downloads Our
More informationChallenging Case of Pulse Infusion Thrombolysis Using a Unique Pump System for a Patient With Deep Vein Thrombosis: A Case Report
J Cardiol 2002 Feb; 39 2 : 115 119 Challenging Case of Pulse Infusion Thrombolysis Using a Unique Pump System for a Patient With Deep Vein Thrombosis: A Case Report MD Seiji Taro Katsuo Yasushi Fumiyuki
More informationOutcomes Of Combined Rheolytic And Rotational Mechanical Thrombectomy For Total Access Circuit Thrombosis In Hemodialysis Patients
Outcomes Of Combined Rheolytic And Rotational Mechanical Thrombectomy For Total Access Circuit Thrombosis In Hemodialysis Patients Nicholas Petruzzi, MD Raphael Cohen, MD Mark Mantell, MD Timothy W. Clark,
More informationChronic Iliocaval Venous Occlusive Disease
none Chronic Iliocaval Venous Occlusive Disease David Rigberg, M.D. Clinical Professor of Surgery Division of Vascular Surgery University of California Los Angeles Chronic Venous Occlusive Disease Chronic
More informationAccording to the 2004 ACCP Guidelines,1 the
Produced under an educational grant from Possis Medical Inc. and Cordis Endovascular. ggressive DVT Management Strategies and Techniques Experts share their experiences with early intervention using pharmacomechanical
More informationRisk factors for DVT. Venous thrombosis & pulmonary embolism. Anticoagulation (cont d) Diagnosis 1/5/2018. Ahmed Mahmoud, MD
Risk factors for DVT Venous thrombosis & pulmonary embolism Ahmed Mahmoud, MD Surgery ; post op especially for long cases, pelvic operations (THR), Trauma ; long bone fractures, pelvic fractures (posterior
More informationVenous thrombosis & pulmonary embolism. Ahmed Mahmoud, MD
Venous thrombosis & pulmonary embolism Ahmed Mahmoud, MD Risk factors for DVT Surgery ; post op especially for long cases, pelvic operations (THR), Trauma ; long bone fractures, pelvic fractures (posterior
More informationCatheter direct thrombolysis: Role of actilyse in treatment of acute deep venous thrombosis
The Egyptian Journal of Radiology and Nuclear Medicine (2013) 44, 57 62 Egyptian Society of Radiology and Nuclear Medicine The Egyptian Journal of Radiology and Nuclear Medicine www.elsevier.com/locate/ejrnm
More informationSafety and Feasibility of Ultrasound-accelerated Catheter-directed Thrombolysis in Deep Vein Thrombosis
Eur J Vasc Endovasc Surg (2011) 41, 526e532 Safety and Feasibility of Ultrasound-accelerated Catheter-directed Thrombolysis in Deep Vein Thrombosis J. Grommes a, *, R. Strijkers b, A. Greiner a, A.H. Mahnken
More informationTreatment of Axillosubclavian Vein Thrombosis: A Novel Technique for Rapid Removal of Clot Using Low-Dose Thrombolysis
J ENDOVASC THER 733 RAPID COMMUNICATION Treatment of Axillosubclavian Vein Thrombosis: A Novel Technique for Rapid Removal of Clot Using Low-Dose Thrombolysis Frank R. Arko, MD; Paul Cipriano, MD; Eugene
More informationWhat is the optimal time window for treating deep venous thrombosis? Acute vs subacute vs chronic
What is the optimal time window for treating deep venous thrombosis? Acute vs subacute vs chronic Peter A. Schneider, MD Chief of Vascular Therapy Kaiser Foundation Hospital Honolulu, Hawaii Disclosure
More informationDisclosures. DVT: Diagnosis and Treatment. Questions To Ask. Dr. Susanna Shin - DVT: Diagnosis and Treatment. Acute Venous Thromboembolism (VTE) None
Disclosures DVT: Diagnosis and Treatment None Susanna Shin, MD, FACS Assistant Professor University of Washington Acute Venous Thromboembolism (VTE) Deep Venous Thrombosis (DVT) Pulmonary Embolism (PE)
More informationIsolated pharmacomechanical thrombolysis using the Trellis system
Isolated pharmacomechanical thrombolysis using the Trellis system Item Type Book Chapter Authors O Sullivan, GJ Download date 12/10/2018 15:28:08 Link to Item http://hdl.handle.net/10147/302592 Find this
More informationBC Vascular Day. Contents. November 3, Abdominal Aortic Aneurysm 2 3. Peripheral Arterial Disease 4 6. Deep Venous Thrombosis 7 8
BC Vascular Day Contents Abdominal Aortic Aneurysm 2 3 November 3, 2018 Peripheral Arterial Disease 4 6 Deep Venous Thrombosis 7 8 Abdominal Aortic Aneurysm Conservative Management Risk factor modification
More informationBedside Ultrasound for DVT. Linear Probe. Leg Veins
Bedside Ultrasound for DVT J. Christian Fox, MD, RDMS, FAAEM, FAIUM Director of Emergency Ultrasound Fellowship University of California, Irvine Jchrsitianfox@gmail.com Linear Probe High frequency transducer
More informationAnticoagulation therapy following endovascular treatment of iliofemoral deep vein thrombosis
Anticoagulation therapy following endovascular treatment of iliofemoral deep vein thrombosis Tim Sebastian, M.D. University Hospital Zurich Clinic for Angiology Disclosure Speaker name: Tim Sebastian I
More informationAs with any intervention, selection of an appropriate
DVT: ccess Decisions for Interventions ssessing the advantages and disadvantages of venous access options is crucial for safe and successful DVT intervention. Y JOHN. KUFMN, MD, MS, FSIR, FH, FCIRSE, EIR
More informationVenous Ulcers. A Little Basic Science. An Aggressive Prescription to Aid Healing. Why do venous ulcers occur? Ambulatory venous hypertension!
UCSF Vascular Symposium April 26-28, 2012 San Francisco, California True statements about the management of venous ulcers include: An Aggressive Prescription to Aid Healing Anthony J. Comerota, MD, FACS,
More informationLysis-Assisted Balloon (LAB) Thrombectomy
Lysis-Assisted Balloon (LAB) Thrombectomy Panagiotis M. Kitrou MD, MSc, PhD, EBIR Consultant Interventional Radiologist Interventional Radiology Dpt. Patras University Hospital Greece Facts & Figures Thrombosis:
More informationThe Conservative and Active Management of Post Thrombotic Syndrome
The Conservative and Active Management of Post Thrombotic Syndrome Stephen Black Consultant Vascular Surgeon Clinical Lead for Venous and Lymphoedema Surgery Guys and St Thomas Hospital London How important
More informationImaging, it s central role in planning and guiding intervention. Prof. Luis Izquierdo. MD, PhD, FEBVS
Imaging, it s central role in planning and guiding intervention Prof. Luis Izquierdo. MD, PhD, FEBVS IMPORTANT INFORMATION: These materials are intended to describe common clinical considerations and procedural
More informationPrevention and management of deep venous thrombosis (DVT) John Fletcher Wound Care Association of New South Wales
Prevention and management of deep venous thrombosis (DVT) John Fletcher Wound Care Association of New South Wales Merimbula, 6 th November 2010 University of Sydney Department of Surgery Westmead Hospital
More informationVIVO-EU Results: Prospective European Study of the Zilver Vena TM Venous Stent in the Treatment of Symptomatic Iliofemoral Venous Outflow Obstruction
VIVO-EU Results: Prospective European Study of the Zilver Vena TM Venous Stent in the Treatment of Symptomatic Iliofemoral Venous Outflow Obstruction Gerard J O Sullivan, M.D. and Jennifer McCann-Brown,
More informationPulse-spray Pharmacomechanical Thrombolysis for Proximal Deep Vein Thrombosis
Eur J Vasc Endovasc Surg 31, 204 211 (2006) doi:10.1016/j.ejvs.2005.08.010, available online at http://www.sciencedirect.com on Pulse-spray Pharmacomechanical Thrombolysis for Proximal Deep Vein Thrombosis
More informationPulmonary Embolism Is it the Greatest Danger in Deep Vein Thrombosis?
Difficult issues in Deep Vein Thrombosis: Pulmonary Embolism Is it the Greatest Danger in Deep Vein Thrombosis? Raluca Dulgheru; C Gherghinescu; B Dorobat; H Muresan; R Darabont; M Cinteza; D Vinereanu
More information4/30/2018 CLOT+ In patients with an acute proximal deep vein thrombosis, pharmacomechanical catheter-directed thrombolysis does not reduce t
In patients with an acute proximal deep vein thrombosis, pharmacomechanical catheter-directed thrombolysis does not reduce the rate of post-thrombotic syndrome Question In patients who have symptomatic
More informationEvidence for endovascular therapy of iliofemoral DVT: CAVENT, ATTRACT, CAVA and more to come
Evidence for endovascular therapy of iliofemoral DVT: CAVENT, ATTRACT, CAVA and more to come Stephen Black Consultant Vascular Surgeon Reader in Venous Surgery Or rephrased To lyse or not to lyse: that
More informationPAPER. Aggressive Percutaneous Mechanical Thrombectomy of Deep Venous Thrombosis
PAPER Aggressive Percutaneous Mechanical Thrombectomy of Deep Venous Thrombosis Early Clinical Results Frank R. Arko, MD; Charles M. Davis III, BS; Erin H. Murphy, MD; Stephen T. Smith, MD; Carlos H. Timaran,
More information